TNFRSF17 and plasma cell myeloma: CAR transduction in Jurkat cells confirmed strong activation after exposure to MM.1S myeloma cells; however, we noted baseline activation above that of control anti-BCMA CAR-transduced Jurkats (Supplementary Fig. 4A).